KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Novavax (NVAX) Long-Term Debt Issuances (2016)

Historic Long-Term Debt Issuances for Novavax (NVAX) over the last 3 years, with Q1 2016 value amounting to $325.0 million.

  • Novavax's Long-Term Debt Issuances changed N/A to $325.0 million in Q1 2016 from the same period last year, while for Dec 2016 it was $325.0 million, marking a year-over-year change of. This contributed to the annual value of $175.2 million for FY2022, which is N/A changed from last year.
  • Per Novavax's latest filing, its Long-Term Debt Issuances stood at $325.0 million for Q1 2016.
  • Over the past 5 years, Novavax's Long-Term Debt Issuances peaked at $325.0 million during Q1 2016, and registered a low of $100000.0 during Q1 2012.
  • Over the past 3 years, Novavax's median Long-Term Debt Issuances value was $641000.0 (recorded in 2013), while the average stood at $65.4 million.
  • Within the past 5 years, the most significant YoY rise in Novavax's Long-Term Debt Issuances was 70900.0% (2013), while the steepest drop was 70900.0% (2013).
  • Quarter analysis of 3 years shows Novavax's Long-Term Debt Issuances stood at $550000.0 in 2012, then grew by 16.55% to $641000.0 in 2013, then surged by 50602.03% to $325.0 million in 2016.
  • Its last three reported values are $325.0 million in Q1 2016, $641000.0 for Q2 2013, and $809000.0 during Q1 2013.